PEAK6 Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-39,351
Closed -$1.18M 4901
2015
Q4
$1.18M Buy
39,351
+10,695
+37% +$360K 0.01% 1781
2015
Q3
$903K Buy
28,656
+13,218
+86% +$645K ﹤0.01% 2292
2015
Q2
$747K Sell
15,438
-2,873
-16% -$121K ﹤0.01% 2364
2015
Q1
$794K Buy
18,311
+16,218
+775% +$583K 0.01% 2124
2014
Q4
$55K Sell
2,093
-9,103
-81% -$200K ﹤0.01% 4101
2014
Q3
$199K Buy
11,196
+733
+7% +$15K ﹤0.01% 3311
2014
Q2
$251K Buy
+10,463
New +$212K ﹤0.01% 2985

Other funds holding PGEN

PEAK6 Group's PGEN Position: Q1 2016 in Review

PEAK6 Group sold out of Precigen (PGEN) in Q1 2016, closing a stake of 37,204 shares — an estimated $1.17M sold.

PEAK6 Group first reported a position in PGEN in Q3 2013 and held it in 4 quarters. The position peaked at $1.85M in Q3 2013. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • PEAK6 Group reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 37,204 Precigen shares in Q1 2016, an estimated $1.17M.
  • PEAK6 Group first reported a position in Precigen in Q3 2013 and held it in 4 quarters.
  • PEAK6 Group's Precigen position peaked at $1.85M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.